Compare BBVA & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BBVA | ABT |
|---|---|---|
| Founded | 1857 | 1888 |
| Country | Spain | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.5B | 152.9B |
| IPO Year | N/A | 2006 |
| Metric | BBVA | ABT |
|---|---|---|
| Price | $22.86 | $90.63 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 20 |
| Target Price | N/A | ★ $130.90 |
| AVG Volume (30 Days) | 1.4M | ★ 9.6M |
| Earning Date | 04-30-2026 | 04-16-2026 |
| Dividend Yield | ★ 4.08% | 2.76% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.61 |
| Revenue | N/A | ★ $44,328,000,000.00 |
| Revenue This Year | $29.69 | $10.75 |
| Revenue Next Year | $5.39 | $8.10 |
| P/E Ratio | ★ $11.24 | $142.66 |
| Revenue Growth | N/A | ★ 5.67 |
| 52 Week Low | $14.63 | $81.97 |
| 52 Week High | $26.20 | $137.49 |
| Indicator | BBVA | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 53.23 | 53.98 |
| Support Level | $22.50 | $84.96 |
| Resistance Level | $23.99 | $112.81 |
| Average True Range (ATR) | 0.40 | 1.89 |
| MACD | 0.04 | 0.80 |
| Stochastic Oscillator | 60.19 | 79.73 |
Despite its Spanish origins, Banco Bilbao Vizcaya Argentaria generates only around one-fourth of its profits in Spain. We expect that on a normalized basis, BBVA's market-leading Mexican bank should contribute half of its earnings, while its Turkish operation should account for another 15%. The balance of BBVA's earnings comes from smaller operations in South America. BBVA is overwhelmingly a retail and commercial bank, with corporate and investment banking forming a minor part of the overall business. BBVA also offers insurance and investment products through its banking networks.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.